97 related articles for article (PubMed ID: 2910487)
1. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
Sweet P; Chan PK; Slater LM
Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
Chan PK; Aldrich MB; Yung BY
Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by cyclosporin A of daunorubicin efficacy in Ehrlich ascites carcinoma and murine hepatoma 129.
Meador J; Sweet P; Stupecky M; Wetzel M; Murray S; Gupta S; Slater L
Cancer Res; 1987 Dec; 47(23):6216-9. PubMed ID: 3677073
[TBL] [Abstract][Full Text] [Related]
4. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
Tapiero H; Nguyen-Ba G; Lampidis TJ
Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
Slater LM; Sweet P; Stupecky M; Gupta S
J Clin Invest; 1986 Apr; 77(4):1405-8. PubMed ID: 3457021
[TBL] [Abstract][Full Text] [Related]
6. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
[TBL] [Abstract][Full Text] [Related]
7. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M
Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
9. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
Yung BY; Bor AM; Chan PK
Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
11. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin.
Hu XF; de Luise M; Martin TJ; Zalcberg JR
Eur J Cancer; 1990; 26(7):814-7. PubMed ID: 2145901
[TBL] [Abstract][Full Text] [Related]
13. Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.
Vayuvegula B; Slater L; Meador J; Gupta S
Cancer Chemother Pharmacol; 1988; 22(2):163-8. PubMed ID: 3165724
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro.
Osann K; Sweet P; Slater LM
Cancer Chemother Pharmacol; 1992; 30(2):152-4. PubMed ID: 1600596
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants.
Zatsepina OV; Todorov IT; Philipova RN; Krachmarov CP; Trendelenburg MF; Jordan EG
Eur J Cell Biol; 1997 May; 73(1):58-70. PubMed ID: 9174672
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
20. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells.
Berman E; McBride M
Blood; 1992 Jun; 79(12):3267-73. PubMed ID: 1596567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
